Search details
1.
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
N Engl J Med
; 386(23): 2188-2200, 2022 06 09.
Article
in English
| MEDLINE | ID: mdl-35443106
2.
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.
Clin Infect Dis
; 78(4): 995-1004, 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38092042
3.
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Clin Infect Dis
; 2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38663013
4.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Clin Infect Dis
; 76(5): 861-870, 2023 03 04.
Article
in English
| MEDLINE | ID: mdl-36259527
5.
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial.
Clin Infect Dis
; 77(7): 991-1009, 2023 Oct 05.
Article
in English
| MEDLINE | ID: mdl-37207617
6.
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
Clin Infect Dis
; 77(4): 593-605, 2023 08 22.
Article
in English
| MEDLINE | ID: mdl-37052343
7.
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study.
Clin Gastroenterol Hepatol
; 21(3): 713-722.e3, 2023 03.
Article
in English
| MEDLINE | ID: mdl-35436624
8.
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
J Antimicrob Chemother
; 78(9): 2361-2365, 2023 09 05.
Article
in English
| MEDLINE | ID: mdl-37539492
9.
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.
HIV Med
; 24(8): 914-924, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37038245
10.
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.
HIV Med
; 24(3): 267-278, 2023 03.
Article
in English
| MEDLINE | ID: mdl-35938381
11.
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
HIV Med
; 24(1): 27-36, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35527425
12.
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial.
Clin Infect Dis
; 75(6): 975-986, 2022 09 29.
Article
in English
| MEDLINE | ID: mdl-35079789
13.
Epidemiology, comorbidities at diagnosis and outcomes associated with HIV late diagnosis from 2010 to 2019 in a Belgian reference centre: A retrospective study.
HIV Med
; 23(11): 1184-1194, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36356949
14.
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
HIV Med
; 23(8): 895-910, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35233903
15.
Observational cohort study of rilpivirine (RPV) utilization in Europe.
AIDS Res Ther
; 19(1): 38, 2022 08 06.
Article
in English
| MEDLINE | ID: mdl-35933352
16.
A public health value-based healthcare paradigm for HIV.
BMC Health Serv Res
; 22(1): 13, 2022 Jan 02.
Article
in English
| MEDLINE | ID: mdl-34974833
17.
Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort Study.
Ann Intern Med
; 174(6): 768-776, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33721519
18.
The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study.
J Infect Dis
; 223(4): 632-637, 2021 02 24.
Article
in English
| MEDLINE | ID: mdl-32640015
19.
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE.
Clin Infect Dis
; 73(2): 195-202, 2021 07 15.
Article
in English
| MEDLINE | ID: mdl-32448894
20.
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care.
Clin Infect Dis
; 73(11): e4166-e4174, 2021 12 06.
Article
in English
| MEDLINE | ID: mdl-32706859